Literature DB >> 23860604

MRI T2 hypointensity of metastatic brain tumors from gastric and colonic cancers.

Hirofumi Hirano1, Shunichi Yokoyama, Shunji Yunoue, Hajime Yonezawa, Kazutaka Yatsushiro, Takako Yoshioka, Ryosuke Hanaya, Hiroshi Tokimura, Kazunori Arita.   

Abstract

BACKGROUND: Metastatic brain tumors from gastric and colon cancers are frequently revealed by hypointensity on T2-weighted magnetic resonance images (MRIs). However, the reason for this T2 hypointensity has yet to be clarified. We hypothesize that it is due to collagen deposition within the tissues.
METHODS: Seven metastatic brain tumors, from 3 gastric cancers and 4 colon cancers were investigated. The degree of hypointensity of these tumors in T2-weighted images was quantitatively assessed as the ratio of gray-scale densities of tumor to brain using ImageJ. The result was compared with the amount of collagen in the resected specimens, which was quantified by ImageJ analysis software, utilizing the colour deconvolution method following Azan-Mallory staining. The degree of hypointensity was also compared with the ratio of viable epithelial component area/whole tissue area. Additionally, collagen distribution was studied by immunohistochemical staining.
RESULTS: There was a clear negative correlation between intensity in T2-weighted images of these metastatic tumors and the amount of collagen they contained (R (2) = 0.766). However, there was no significant correlation between the T2 intensity and the ratio of viable epithelial component. Immunohistochemical analysis revealed that collagen types I, III, VII, X, and XI were expressed in the epithelial components and types IV, V, and VI were expressed in the stromal areas of the metastatic tumors. Collagen deposition was observed not only in stromal fibrous areas, but also in cytoplasmic areas in these metastatic tumors.
CONCLUSIONS: Hypointensity of metastatic brain tumors arising from gastric and colonic cancers may be due to the accumulation of collagen in the tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860604     DOI: 10.1007/s10147-013-0596-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  21 in total

1.  Collagen: a possible prediction mark for gastric cancer.

Authors:  Ying Yin; Yuan Zhao; Ai-Qing Li; Jian-Min Si
Journal:  Med Hypotheses       Date:  2008-10-31       Impact factor: 1.538

2.  Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Cláudia A A de Paula; Ana M Mader; Jaques Waisberg; Maria A Pinhal; Andreas Friedl; Leny Toma; Helena B Nader
Journal:  Cell Tissue Res       Date:  2011-10-11       Impact factor: 5.249

3.  Pineal region metastasis appearing as hypointensity on T2-weighted magnetic resonance imaging--case report.

Authors:  H Kanai; K Yamada; N Aihara; K Watanabe
Journal:  Neurol Med Chir (Tokyo)       Date:  2000-05       Impact factor: 1.742

4.  Skeletal muscle fibrosis: the effect of stromal-derived factor-1α-loaded collagen scaffolds.

Authors:  Sander Grefte; Anne Marie Kuijpers-Jagtman; Ruurd Torensma; Johannes W Von den Hoff
Journal:  Regen Med       Date:  2010-09       Impact factor: 3.806

5.  Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.

Authors:  Satoshi Ohno; Mitsuo Tachibana; Toshiyuki Fujii; Shuhei Ueda; Hirofumi Kubota; Naofumi Nagasue
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

6.  Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.

Authors:  Alessandro Pini; Ronen Shemesh; Chrishan S Samuel; Ross A D Bathgate; Arie Zauberman; Chen Hermesh; Assaf Wool; Daniele Bani; Galit Rotman
Journal:  J Pharmacol Exp Ther       Date:  2010-09-08       Impact factor: 4.030

7.  Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.

Authors:  G Brown; A G Radcliffe; R G Newcombe; N S Dallimore; M W Bourne; G T Williams
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

8.  Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors.

Authors:  Genaro A Ramirez Correa; Serena Zacchigna; Nikola Arsic; Lorena Zentilin; Alessandro Salvi; Gianfranco Sinagra; Mauro Giacca
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

9.  Promotion of collagen production by human fibroblasts with gastric cancer cells in vitro.

Authors:  Y Naito; I Kino; K Horiuchi; D Fujimoto
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

10.  MRI of gastric carcinoma: results of T and N-staging in an in vitro study.

Authors:  Il Young Kim; Sang Won Kim; Hyeong Cheol Shin; Moon Soo Lee; Dong Jun Jeong; Chang Jin Kim; Young Tong Kim
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

View more
  3 in total

1.  MR imaging profile and histopathological characteristics of tumour vasculature, cell density and proliferation rate define two distinct growth patterns of human brain metastases from lung cancer.

Authors:  Makoto Kiyose; Eva Herrmann; Jenny Roesler; Pia S Zeiner; Joachim P Steinbach; Marie-Therese Forster; Karl H Plate; Marcus Czabanka; Thomas J Vogl; Elke Hattingen; Michel Mittelbronn; Stella Breuer; Patrick N Harter; Simon Bernatz
Journal:  Neuroradiology       Date:  2022-10-03       Impact factor: 2.995

2.  Neuroimaging diagnosis of pineal region tumors-quest for pathognomonic finding of germinoma.

Authors:  Ryuji Awa; Francia Campos; Kazunori Arita; Kazuhiko Sugiyama; Atsushi Tominaga; Kaoru Kurisu; Fumiyuki Yamasaki; Prasanna Karki; Hiroshi Tokimura; Yoshihiko Fukukura; Yukihiko Fujii; Ryosuke Hanaya; Tatsuki Oyoshi; Hirofumi Hirano
Journal:  Neuroradiology       Date:  2014-04-29       Impact factor: 2.804

3.  Imaging diagnosis of basal ganglia germ cell tumors: subtype features subtype imaging features of GCTs.

Authors:  Wei Li; Xin Kong; Jun Ma
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.